Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pseudomyxoma peritonei]

V Quiel1

  • 1Frauenklinik, Südharz-Krankenhauses Nordhausen GmbH.

Zentralblatt Fur Gynakologie
|January 1, 1994
PubMed
Summary

Pseudomyxoma peritonei is a rare condition involving mucinous material buildup. Surgery is the primary treatment, with supportive therapies improving patient quality of life.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Mucocele of the vermiform appendix].

Zentralblatt fur Gynakologie·2000
Same author

[Desmoid tumor of the breast].

Zentralblatt fur Gynakologie·2000
Same author

[Combined intra- and extra-uterine pregnancy as a complication of ovarian stimulation and homologous insemination].

Zentralblatt fur Gynakologie·1998
Same author

[Type I allergy to latex after gynecologic examination].

Zentralblatt fur Gynakologie·1996
Same author

[Desmoplastic small cell tumor with multi-phenotype differentiation].

Zentralblatt fur Gynakologie·1995
Same author

[Sex counseling of female paraplegic patients].

Zeitschrift fur arztliche Fortbildung·1994

Area of Science:

  • Oncology
  • Gastroenterology
  • Surgical Pathology

Context:

  • Pseudomyxoma peritonei (PMP) is a rare clinical entity characterized by mucinous and gelatinous ascites and peritoneal implants.
  • PMP often necessitates extensive surgical intervention, frequently involving multiple laparotomies.
  • Adjuvant therapies and long-term nutritional support are crucial for managing advanced stages.

Purpose:

  • To outline the current understanding and management strategies for Pseudomyxoma peritonei.
  • To highlight the role of surgical intervention as the cornerstone of PMP treatment.
  • To discuss the potential benefits of adjuvant chemo- or immunotherapy and nutritional support.

Summary:

  • Pseudomyxoma peritonei involves the accumulation of mucinous material within the peritoneal cavity, affecting organs like the peritoneum, intestines, and omentum.
  • Surgical resection is the primary therapeutic approach, often requiring repeated surgical procedures.
  • Chemotherapy, immunotherapy, and long-term nutritional support can serve as adjuncts to improve outcomes and quality of life.

Impact:

  • Establishes surgical therapy as the principal treatment modality for Pseudomyxoma peritonei.
  • Underscores the importance of multidisciplinary care, including surgical, oncological, and nutritional support.
  • Provides a framework for managing this rare malignancy, aiming to enhance patient survival and well-being.

Related Experiment Videos